Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:37:57.713Z.
Calculation as of: 2026-10-06T21:37:57.713Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 11162aacdea541bd0c22d895134fbf2d0042bdecc45a18e93c77b8e06c908ab2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-04-15.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$28.08M
EV/FCF Ratio
N/A
TTM Avg
130.14x
3Y Avg
130.14x
5Y Avg
55.86x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OneMedNet Corporation (ONMD) | $28.31M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | N/A | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | N/A | 130.14x | 130.14x | 55.86x |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A | N/A | N/A | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-04-15 | 2.73x |
| 2025-04-14 | 2.60x |
| 2025-04-11 | 2.44x |
| 2025-04-10 | 2.72x |
| 2025-04-09 | 2.69x |
| 2025-04-08 | 2.76x |
| 2025-04-07 | 2.64x |
| 2025-04-04 | 2.57x |
| 2025-04-03 | 2.62x |
| 2025-04-02 | 2.76x |
| 2025-04-01 | 2.79x |
| 2025-03-31 | 2.76x |
| 2025-03-28 | 2.83x |
| 2025-03-27 | 2.89x |
| 2025-03-26 | 2.92x |
| 2025-03-25 | 2.86x |
| 2025-03-24 | 2.89x |
| 2025-03-21 | 2.76x |
| 2025-03-20 | 2.90x |
| 2025-03-19 | 2.94x |
| 2025-03-18 | 3.00x |
| 2025-03-17 | 3.16x |
| 2025-03-14 | 3.29x |
| 2025-03-13 | 3.32x |
| 2025-03-12 | 3.40x |
| 2025-03-11 | 3.38x |
| 2025-03-10 | 3.36x |
| 2025-03-07 | 3.50x |
| 2025-03-06 | 3.09x |
| 2025-03-05 | 3.53x |
| 2025-03-04 | 3.69x |
| 2025-03-03 | 4.05x |
| 2025-02-28 | 4.02x |
| 2025-02-27 | 4.17x |
| 2025-02-26 | 4.28x |
| 2025-02-25 | 4.37x |
| 2025-02-24 | 4.48x |
| 2025-02-21 | 4.34x |
| 2025-02-20 | 4.26x |
| 2025-02-19 | 4.19x |
| 2025-02-18 | 4.16x |
| 2025-02-14 | 4.13x |
| 2025-02-13 | 4.23x |
| 2025-02-12 | 4.14x |
| 2025-02-11 | 4.15x |
| 2025-02-10 | 4.22x |
| 2025-02-07 | 4.27x |
| 2025-02-06 | 4.34x |
| 2025-02-05 | 4.34x |
| 2025-02-04 | 4.44x |
| 2025-02-03 | 4.37x |
| 2025-01-31 | 4.48x |
| 2025-01-30 | 4.44x |
| 2025-01-29 | 4.51x |
| 2025-01-28 | 4.76x |
| 2025-01-27 | 4.58x |
| 2025-01-24 | 5.60x |
| 2025-01-23 | 5.53x |
| 2025-01-22 | 5.67x |
| 2025-01-21 | 5.60x |
| 2025-01-17 | 4.93x |
| 2025-01-16 | 4.69x |
| 2025-01-15 | 4.51x |
| 2025-01-14 | 4.44x |
| 2025-01-13 | 4.48x |
| 2025-01-10 | 4.79x |
| 2025-01-08 | 5.00x |
| 2025-01-07 | 5.50x |
| 2025-01-06 | 5.81x |
| 2025-01-03 | 5.85x |
| 2025-01-02 | 5.74x |
| 2024-12-31 | 5.64x |
| 2024-12-30 | 5.99x |
| 2024-12-27 | 5.53x |
| 2024-12-26 | 5.71x |
| 2024-12-24 | 5.71x |
| 2024-12-23 | 5.71x |
| 2024-12-20 | 5.78x |
| 2024-12-19 | 4.55x |
| 2024-12-18 | 4.25x |
| 2024-12-17 | 3.62x |
| 2024-12-16 | 3.61x |
| 2024-12-13 | 3.59x |
| 2024-12-12 | 3.58x |
| 2024-12-11 | 3.02x |
| 2024-12-10 | 3.04x |
| 2024-12-09 | 3.06x |
| 2024-12-06 | 3.10x |
| 2024-12-05 | 2.17x |
| 2024-12-04 | 2.30x |
| 2024-12-03 | 2.28x |
| 2024-12-02 | 2.19x |
| 2024-11-29 | 1.99x |
| 2024-11-27 | 1.93x |
| 2024-11-26 | 2.06x |
| 2024-11-25 | 1.94x |
| 2024-11-22 | 1.90x |
| 2024-11-21 | 1.83x |
| 2024-11-20 | 1.83x |
| 2024-11-19 | 1.84x |
| 2024-11-18 | 1.88x |
| 2024-11-15 | 1.89x |
| 2024-11-14 | 2.05x |
| 2024-11-13 | 1.97x |
| 2024-11-12 | 2.00x |
| 2024-11-11 | 1.72x |
| 2024-11-08 | 1.63x |
| 2024-11-07 | 1.61x |
| 2024-11-06 | 1.77x |
